英语翻译The primary objective of this 6-week,parallel-group,open-label,randomized,multicenter trial was to com- pare rosuvastatin with atorvastatin,pravastatin,and simvastatin across dose ranges for reduction of low- density lipoprotein (LDL) cho
来源:学生作业帮助网 编辑:作业帮 时间:2024/08/05 08:53:19
![英语翻译The primary objective of this 6-week,parallel-group,open-label,randomized,multicenter trial was to com- pare rosuvastatin with atorvastatin,pravastatin,and simvastatin across dose ranges for reduction of low- density lipoprotein (LDL) cho](/uploads/image/z/13640912-8-2.jpg?t=%E8%8B%B1%E8%AF%AD%E7%BF%BB%E8%AF%91The+primary+objective+of+this+6-week%2Cparallel-group%2Copen-label%2Crandomized%2Cmulticenter+trial+was+to+com-+pare+rosuvastatin+with+atorvastatin%2Cpravastatin%2Cand+simvastatin+across+dose+ranges+for+reduction+of+low-+density+lipoprotein+%28LDL%29+cho)
英语翻译The primary objective of this 6-week,parallel-group,open-label,randomized,multicenter trial was to com- pare rosuvastatin with atorvastatin,pravastatin,and simvastatin across dose ranges for reduction of low- density lipoprotein (LDL) cho
英语翻译
The primary objective of this 6-week,parallel-group,open-label,randomized,multicenter trial was to com- pare rosuvastatin with atorvastatin,pravastatin,and simvastatin across dose ranges for reduction of low- density lipoprotein (LDL) cholesterol.Secondary objec- tives included comparing rosuvastatin with comparators for other lipid modifications and achievement of Na- tional Cholesterol Education Program Adult Treatment Panel III and Joint European Task Force LDL cholesterol goals.After a dietary lead-in period,2,431 adults with hypercholesterolemia (LDL cholesterol >160 and
英语翻译The primary objective of this 6-week,parallel-group,open-label,randomized,multicenter trial was to com- pare rosuvastatin with atorvastatin,pravastatin,and simvastatin across dose ranges for reduction of low- density lipoprotein (LDL) cho
这项为期6周的主要目标,平行组,开放标签,随机,多中心试验是COM的削减与阿托伐他汀,普伐他汀瑞舒伐他汀,辛伐他汀和跨剂量为低密度脂蛋白(LDL)胆固醇降低幅度.二级目标具体包括比较与其他脂质的修改和钠佐丹奴国胆固醇教育计划成人治疗小组第三和欧洲联合专责小组低密度脂蛋白胆固醇目标的实现比较瑞舒伐他汀.经过用药后,在时期,2431成人高胆固醇血症(低密度脂蛋白胆固醇> 160和“